Value through Innovation25 May 2013

Diabetes News and Information

This section includes information and resources about Diabetes for journalists: Boehringer Ingelheim press releases, background information, related press kits and a collection of images and videos.

Diabetes Press Releases

back 1 2 3 4 5 6 7 8 9 next

24.05.2013	Boehringer Ingelheim and Eli Lilly & Company launch type 2 diabetes educational game, "Complications Combat" - For Non-U.S. and Non-UK media
26.03.2013	Boehringer Ingelheim and Eli Lilly and Company announce acceptance of European marketing authorisation application for investigational Type 2 Diabetes treatment empagliflozin* - EX US & UK Medical Media Only
19.03.2013	Boehringer Ingelheim and Lilly initiate MARLINA™ clinical trial to evaluate use of Trajenta® (linagliptin) in patients with type 2 diabetes and albuminuria - For Non-U.S. and Non-U.K. Media
25.02.2013	Healthcare Innovation World Cup: Call for Breakthrough Ideas to Tackle Diabetes
17.01.2013	Boehringer Ingelheim and the EFSD call for grant applications in diabetes research

back 1 2 3 4 5 6 7 8 9 next

Further Press Releases in our Archive

Diabetes Related News Room

Resources
Videos

Diabetes Related Documents

Diabetes Video Gallery

Mode of Action of DPP-4 Inhibitors
- Watch the Video
Diabetes Complications Animation
- Watch the video
Professor Anthony Barnett: Advantages of DPP-4 inhibitors in the treatment of type 2 diabetes
- Watch the Video(WMV)
Professor Anthony Barnett: Renal impairment in type 2 diabetes
- Watch the video(WMV)
Professor Anthony Barnett: The potential of linagliptin
- Watch the video(WMV)